Stay updated on IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    System revision history updated to add v3.5.0 and remove v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:21:28.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-06T19:07:27.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page history shows a new revision (v3.4.2) replacing the previous revision (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The history now shows a new revision entry (v3.4.1) added to the record, and the previous revision (v3.4.0) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:14:36.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page history shows a new revision label from v3.3.3 to v3.3.4, which is a minor backend update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:49:40.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    Added a footer notice 'Revision: v3.3.3'. Removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' reference.
    Difference
    0.1%
    Check dated 2025-12-17T20:14:11.000Z thumbnail image

Stay in the know with updates to IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Glargine-Aspart in Type 2 Diabetes Clinical Trial page.